The Problem isn’t that they make money from their superior product. The problem, as I understand, is that they use an unethical business model to do so, heavily distorting the options available to doctors and locking them into using their product.
At the very least, I think they should openly justify their pricing strategy. The public and Danaher’s customers should know about their profits, per-machine and per-test, so they can negotiate fairer deals.
The Problem isn’t that they make money from their superior product. The problem, as I understand, is that they use an unethical business model to do so, heavily distorting the options available to doctors and locking them into using their product.
At the very least, I think they should openly justify their pricing strategy. The public and Danaher’s customers should know about their profits, per-machine and per-test, so they can negotiate fairer deals.